John E. Coligan

11.0k total citations · 1 hit paper
186 papers, 9.1k citations indexed

About

John E. Coligan is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John E. Coligan has authored 186 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Immunology, 55 papers in Molecular Biology and 52 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John E. Coligan's work include Immune Cell Function and Interaction (71 papers), T-cell and B-cell Immunology (66 papers) and Monoclonal and Polyclonal Antibodies Research (47 papers). John E. Coligan is often cited by papers focused on Immune Cell Function and Interaction (71 papers), T-cell and B-cell Immunology (66 papers) and Monoclonal and Polyclonal Antibodies Research (47 papers). John E. Coligan collaborates with scholars based in United States, Spain and Netherlands. John E. Coligan's co-authors include Francisco Borrego, Andrëw G. Brööks, Frits Koning, W L Maloy, Matthias Ulbrecht, Elisabeth H. Weiss, Thomas J. Kindt, Alina I. Marusina, Madhan Masilamani and Juraj Kabát and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

John E. Coligan

182 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis

1998 583 citations Francisco Borrego, John E. Coligan et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by John E. Coligan

Since Specialization

Citations

This map shows the geographic impact of John E. Coligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Coligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Coligan more than expected).

Fields of papers citing papers by John E. Coligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Coligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Coligan. The network helps show where John E. Coligan may publish in the future.

Co-authorship network of co-authors of John E. Coligan

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Coligan. A scholar is included among the top collaborators of John E. Coligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Coligan. John E. Coligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Natural killer cell activity and dysfunction in Hermansky‐Pudlak syndrome 2016 ·British Journal of Haematology ·Aleksandra Gil‐Krzewska, Yousuke Murakami, Giovanna Peruzzi, Kevin O’Brien, Melissa A. Merideth, Andrew R. Cullinane, William A. Gahl, John E. Coligan, Bernadette R. Gochuico, Konrad Krzewski	17
2	Chediak-Higashi syndrome: Lysosomal trafficking regulator domains regulate exocytosis of lytic granules but not cytokine secretion by natural killer cells 2015 ·Journal of Allergy and Clinical Immunology ·Aleksandra Gil‐Krzewska, Stephanie M. Wood, Yousuke Murakami, Victoria Nguyen, Samuel C. C. Chiang, Andrew R. Cullinane, Giovanna Peruzzi, William A. Gahl, John E. Coligan, Wendy J. Introne, Yenan T. Bryceson, Konrad Krzewski	43
3	A Single Residue, Arginine 65, Is Critical for the Functional Interaction of Leukocyte-Associated Inhibitory Receptor-1 with Collagens 2009 ·The Journal of Immunology ·Xiaobin Tang, Sriram Narayanan, Giovanna Peruzzi, (unknown), Kannan Natarajan, David H. Margulies, John E. Coligan, Francisco Borrego	26
4	Characterization of the in vivo function of the leukocyte-associated Ig-like receptor (LAIR)-1 (90.27) 2009 ·The Journal of Immunology ·(unknown), (unknown), John E. Coligan, (unknown)	0
5	Characterization of the interaction between human LAIR-1 and collagens. (101.8) 2007 ·The Journal of Immunology ·(unknown), Sriram Narayanan, John E. Coligan, Francisco Borrego	1
6	IL-21 Down-Regulates NKG2D/DAP10 Expression on Human NK and CD8+ T Cells 2006 ·The Journal of Immunology ·Steven Burgess, Alina I. Marusina, (unknown), Francisco Borrego, John E. Coligan	101
7	GATA-3 Is an Important Transcription Factor for Regulating Human NKG2A Gene Expression 2005 ·The Journal of Immunology ·Alina I. Marusina, Dae‐Ki Kim, Louis D. Lieto, Francisco Borrego, John E. Coligan	35
8	Cutting Edge: NKG2D Is a Costimulatory Receptor for Human Naive CD8+ T Cells 2005 ·The Journal of Immunology ·Kerima Maasho, Jessica Opoku‐Anane, Alina I. Marusina, John E. Coligan, Francisco Borrego	152
9	The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor 2004 ·Molecular Immunology ·Francisco Borrego, Madhan Masilamani, Juraj Kabát, Tolib B. Sanni, John E. Coligan	70
10	Short protocols in protein science : a compendium of methods from Current protocols in protein science 2003 ·J. Wiley eBooks ·John E. Coligan	12
11	Human CD94 Gene Expression: Dual Promoters Differing in Responsiveness to IL-2 or IL-15 2003 ·The Journal of Immunology ·Louis D. Lieto, Francisco Borrego, (unknown), John E. Coligan	22
12	NK Cell CD94/NKG2A Inhibitory Receptors Are Internalized and Recycle Independently of Inhibitory Signaling Processes 2002 ·The Journal of Immunology ·Francisco Borrego, Juraj Kabát, Tolib B. Sanni, John E. Coligan	36
13	The Murine Liver-Specific Nonclassical MHC Class I Molecule Q10 Binds a Classical Peptide Repertoire 2000 ·The Journal of Immunology ·Francesca Zappacosta, Piotr Tabaczewski, Kenneth C. Parker, John E. Coligan, Iwona Stroynowski	18
14	Activating Transcription Factor-2 Regulates Phosphoenolpyruvate Carboxykinase Transcription through a Stress-inducible Mitogen-activated Protein Kinase Pathway 1998 ·Journal of Biological Chemistry ·JaeHun Cheong, John E. Coligan, Jon D. Shuman	47
15	NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor 1997 ·The Journal of Experimental Medicine ·Andrëw G. Brööks, Phillip E. Posch, (unknown), Francisco Borrego, John E. Coligan	204
16	Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1,-DR 11, -DR13, and -DR52 1996 ·Immunogenetics ·Frank A. W. Verreck, (unknown), Jan W. Drijfhout, Reinout Amons, John E. Coligan, Frits Koning	39
17	Mouse autoreactive γ/δ T cells II. Molecular characterization of the T cell receptor 1992 ·European Journal of Immunology ·Ángel Ezquerra, D B Wilde, Thomas J. McConnell, (unknown), (unknown), Ethan M. Shevach, John E. Coligan	23
18	Signals controlling alternative splicing of major histocompatibility complex H-2 class I pre-mRNA 1988 ·Immunogenetics ·Diane E. Handy, James McCluskey, Andrew M. Lew, John E. Coligan, David H. Margulies	14
19	Characterization of carcinoembryonic antigen fractionated by concanavalin A chromatography. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Henry S. Slayter, John E. Coligan	23
20	STRUCTURAL STUDIES OF THE MAJOR GLYCOPROTEIN IN PREPARATIONS WITH CARCINOEMBRYONIC ANTIGEN ACTIVITY 1972 ·The Journal of Experimental Medicine ·William D. Terry, Pierre A. Henkart, John E. Coligan, Charles W. Todd	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact